Trade BRNS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Barinthus Biotherapeutics plc American Depositary Shares (BRNS) is trading at US$0.73, down 0.71% today as of Aug 28, 12:21 EDT. The company has a market capitalisation of US$25.4M. Over the past 52 weeks, BRNS has traded between US$0.51 and US$1.83. On Syfe you can trade BRNS with $0 commission and add it to your watchlist.
| Previous close | US$0.73 |
|---|---|
| Market cap | US$25.4M |
| 52-week range | US$0.51 – US$1.83 |
| Volume | 78.79K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Barinthus Biotherapeutics plc American Depositary Shares
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
Year: 2021
Stay on top of BRNS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
